MS-553

MS-553 · Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for MS-553, covering 2016-03-16 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema [Phase 1]